II. Pathophysiology
- Antithrombin III normally inhibits
- Enhanced by Heparin
III. Epidemiology
- Heterozygotes have 25-50% ATIII functional levels
- First episode of thrombosis occurs ages 10-30 years
IV. Complications
V. Labs
- Functional level Antithrombin III